Vestmark Advisory Solutions, Inc. Crispr Therapeutics Ag Transaction History
Vestmark Advisory Solutions, Inc.
- $3.54 Billion
- Q1 2025
A detailed history of Vestmark Advisory Solutions, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 225,306 shares of CRSP stock, worth $8.39 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
225,306
Previous 244,034
7.67%
Holding current value
$8.39 Million
Previous $9.61 Million
20.18%
% of portfolio
0.22%
Previous 0.37%
Shares
6 transactions
Others Institutions Holding CRSP
# of Institutions
479Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$378 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$226 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$141 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$103 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$94.6 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.9B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....